TWI239337B - Reversible photocoupling nucleic acid and phosphoroamidite - Google Patents
Reversible photocoupling nucleic acid and phosphoroamidite Download PDFInfo
- Publication number
- TWI239337B TWI239337B TW089117263A TW89117263A TWI239337B TW I239337 B TWI239337 B TW I239337B TW 089117263 A TW089117263 A TW 089117263A TW 89117263 A TW89117263 A TW 89117263A TW I239337 B TWI239337 B TW I239337B
- Authority
- TW
- Taiwan
- Prior art keywords
- light
- reversible
- dna
- nucleic acid
- linking
- Prior art date
Links
- 230000002441 reversible effect Effects 0.000 title claims abstract description 18
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 16
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 16
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 16
- SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical compound NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 17
- 229920000642 polymer Polymers 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 12
- 229920002554 vinyl polymer Polymers 0.000 description 10
- -1 amine ester Chemical class 0.000 description 7
- 238000005336 cracking Methods 0.000 description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002079 cooperative effect Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 238000006303 photolysis reaction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004491 Antisense DNA Proteins 0.000 description 2
- 101001007348 Arachis hypogaea Galactose-binding lectin Proteins 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000003816 antisense DNA Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- JTBBWRKSUYCPFY-UHFFFAOYSA-N 2,3-dihydro-1h-pyrimidin-4-one Chemical compound O=C1NCNC=C1 JTBBWRKSUYCPFY-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- MVZNHAMKEVDCNA-PNHWDRBUSA-N 4-amino-1-[(2r,3r,4s,5r)-2-ethenyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@@]1(C=C)[C@H](O)[C@H](O)[C@@H](CO)O1 MVZNHAMKEVDCNA-PNHWDRBUSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002862 amidating effect Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-O hydron;pyrimidine Chemical compound C1=CN=C[NH+]=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-O 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 230000015843 photosynthesis, light reaction Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Description
1239337 , A7 B7 五、發明說明(1 ) [技術領域] 本發明係有關於一種可逆之光連結性核酸與碟隨胺 酯,以及利用此等之光連結與光解裂之方法。更詳一 本發明係關於气反意DNA、抗原dNA、光基因診斷=療 及DNA-蛋白質相互作用解析等方面之應用甚為有用,且 可藉由光來控制生體相關高分子連結構造之形成或特殊歹, 解之新穎可逆之光連結性核酸及其合成中 1 尺τ名用之磷醯胺 酯,以及利用此等材料之光連結與光裂解方法者。 [背景技術] 傳統上,大家都體認到對於生物體機能之闡明或生理 活性機轉,乃至生理活性物質之創新製備而言,、 RNA、PNA及蛋白質等彼此間互相連結或局部之裂解之控 制甚為重要。
例如’控制 DNA-DNA、DNA-RNA、DNA-PNA、DNA 蛋白質等連結構造之形成及該等分子之裂解,對反意 DNA、抗原dna、基因診斷治療 '以及DNA_蛋白質等相 經濟部智慧財產局員工消費合作社印製 互作用之闡明,或根據此等作用對生物體分子構造加以控 制極為重要。 因此,傳統上,有關如何使此等分子連結或裂解之方 案不斷檢討中,而藉由光照射之方法也一直在檢討之列。 然而,至目前為止所報告之實例中,連結收率仍偏低 為 左右,而且亦多有副反應之問題。再者,只有將連 結部分進行特異的光裂解之技術例尚不為人知。 _^ ^決上述以往技術之問題點,本發明乃提供 311755 (請先閱讀背面之注意事項再填寫本頁) “氏張尺度適??準(CNS)A4規格(2_i〇 χ 297公髮)---p- 1239337 A7 B7 五、發明說明(2 ) 一種獲得可選擇性地高度連結收率,而連結部分亦可能進 行特異的光裂解’且可自由而可逆地控制光連結與光裂解 之新技術方法。 [發明之揭示] 為解決上述之問題,本發明首先提供一種由下式(1) 表示之可逆之光連結控制核酸。
(1) 其次,本發明亦提供一種由下式(2)表示之磷醯胺酯Ο _ 請 先 閱 讀 背 面 之 注 意 事 項 i 經濟部智慧財產局員工消費合作社印製
(2) 第二,本發明提供一種光連結方法,其特徵為將光照 射於上述可逆之光連結性核酸與生體相關高分子之反應系 中,使形成兩者之連結構造者。第四,本發明提供一種光 裂解方法’其特”由較短波長之光照射,使可逆之光連 本纸張尺度適用中國國家標準各(210 χ 297公爱)—---- 311755 1239337 A7 B7 五、發明說明(3 ) 結性核酸與生體相關高分子之連結構造裂解者。 (請先閱讀背面之注意事項再填寫本頁) 如上所述之可逆之光連結性核酸,亦即藉由含有光連 結核苷之DNA之光照射,1)使DNA-DNA、DNA-RNA、 DNA-PNA、DNA-蛋白質等能夠進行連結與裂解反應,而 可廣泛利用於a)反意DNA、b)抗原DNA、c)光基因診斷治 療、d)DNA-蛋白質相互作用之解析等。 因此,根據本發明,可獲得95%以上之極高連結收率, 1且可藉由光之作用,使連結部分能夠進行特異之裂解。 [圖式之簡單說明] 第1圖為可逆之光連結與光裂解反應例之吸收光譜 圖。 [發明之最佳實施形態] 本發明具有上述之特徵,有關其實施形態則說明如 下。 > 有關本發明上述式(1)之可逆之光連結性核酸,亦即, 經趣部智慧財產局員工消費合作社印製 含光連結性核苷之DNA,係於嘧碇環之第5位置具有乙烯 基特徵之構造。而該構造中乙烯基之存在,使其與例如 DNA、RNA、PNA及蛋白質等作為反應對象之生體相關高 分子之連結和裂解,可利用光來控制。又,該可逆之光連 結性核酸亦可稱為含乙烯基胞嘧啶機能性核酸。該、可逆之 光連結性核酸,其嘧碇環或核苷部分亦可以有其他可容許 之取代基,而且胺基(NH2)、羥基(0H)由.容許之保護基保 護亦可。本發明亦包含此等分子之衍生物。 式(1)表示之本發明之光連結性核酸,係根據例如下式 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 3 311755 1239337 A7 B7 五、發明說明(4 ) 之步驟1及步驟2之途徑,經由上述式(2)表示之磷醯胺西I 可簡便的合成。 -1^1
0H 步驟1
〇=〒-〇、 OH DNA 步驟2 (請先閱讀背面之注意事項寫本頁) •Γ 於步驟1中,例如使醯胺化劑對5-乙烯基脫氧尿嘧淀 DMTr體起進行反應而合成乙烯基胞,唆驢胺前驅物,接 著使其與1,2, 4-三唑進行反應。此時所使用之醯胺化劑為 下列所示者。
經濟部智慧財產局員工消費合作社印製 I 〇
Cl 人 2-氰,乙基N,N,N’N’-四 異丙基磷醯胺酯 〇_p—〇·_-,__n 人 2-氰乙基N,N-二異丙 基氣化磷醯胺酯 311755 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1239337
A7 五、發明說明(5 ) 一又,步驟2係於DNA合成儀中用固相合成法合成職 .券聚物而達成。 藉光所產生之連結作用,係可在作為反應對象之生 體相關高分子,亦即DNA、RNA、PNA或蛋白質之共存下, 利用光照射而完成之。另一太而 _ „ τ 几取之另方面,有關光裂解反應,可用 較短波長之光予以照射,使連結部位進行特異的裂解。具 體而言,藉由例如以較330nm為長之波長之光激發而發生 光連結反應,以較320nm為短之短波長之光激發可發生裂 解反應。 以光照射之方法而言,可從各種裝置作選擇,例如可 使用透照器(transilluminatoi*)。 以下將藉實施例更詳細說明本發明。 [實施例] <實施例1> (合成) 依據上述反應式之步驟1及步驟2,可合成含乙烯基 胞嘴σ定之機能性核酸作為本發明之可逆之光連結性核酸。 (a)步驟1 於5-乙烯基脫氧尿嘧啶DMTr體(166 mg,0.2 98 mmol) 之CH3CN溶液中,添加酸胺化劑(98.0//L、0,309 mmol) 與含0.5M四唑之CH3CN 2·0 ml,將反應混合物擾拌1 〇 小時後進行萃取操作,將有機層乾燥,於CH3CN共沸,而 得定量228mg之乙烯基胞嘴咬醯胺前驅物。接著,於3 氣化碟(0.32 g,2.10 mmol)、1,2,4_ 三唾(〇·667 g,9.676 mmol)之CH3CN混合溶液中,於0°C分3次添加乙稀基胞 311755 ----------------I----訂-------I (請先閱讀背面之注意事項再填寫本頁) 經脣部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1239337 A7 B7 經濟部智慧財產局員工消費合作社印製 五、發明說明(6 ) 嘧啶醯胺前驅物,攪拌3小時,然後進行萃取操作,將有 機層乾燥,於CH3CN共沸而得75%收率之乙烯基胞嘧啶醯 胺 95.7 mg(0.118 mmol) 〇 表 1 Ή NMR (400 MHz, CDCI3) δ 2.21 (ddd, J = 12Λ Hz, J = 7.4 Hz, J = 6.3 Hz, 1H, Η·2·β),2·35 (ddd,J = 12·1 Hz,J = 6.1 Hz,J = 3·1 Hz,1H,H-2’a), 2.95 (dd,J = 10-6 Hz? J = 3.4 Hz, 1H,H-5,),3.38 (dd,J = 10.6Hz,J = 3.4 Hz, 1H, Η·5,),3.71 (s, 6H, OCH3 x 2), 3.90-3.99 (m, 1H, H-4〇, 4.45-4.48 (m, 3H, H.3*), 4.86 (dd, J = 10.2Hzt 2.0 Hz, 1H, vinyl trans)f 5.60-5.73 (m, 1H, vinyl ds, H-l〇, 6.29 (dd, J = 7.4 Hz, J = 6.1Hz, 1H, Η-Γ), 6.73-6.77 (m, 4H; Η-β to OCH3 x 4), 7.17*7.23 (m, 9H, phenyl), 7.29-7.32 (m, 1H, 7.58 (s, 1H, H-6), 8.23 (bs, 1H, NH). 3lP NMR (CDC13; 85% - H3P04 ia D20 ext. 0 ppm) δ 149.811 & 150.386 (cliastereomer of the products). (b)步驟2 將步驟1所製得之乙烯基胞嘧啶醯胺之CH3CN溶液 (0.1 M, 3 ml),置於全自動DN A合成儀中,使用一般之固 相合成法合成DNA寡聚物,經切取、脫保護後利用高速 液相色層分析法(HPLC)予以精製。 利用ESI-TOFF法測定分子量進行化合物之鑑定。 <實施例2> (可逆之光連結與光解裂) 在作為模板之寡聚物(5’-CACGCGAGCACA- 3’、25 mM)存在下,將欲連結之募聚物(5’-TGTGCT-3’、20 mM) 及含乙烯基胞嘴咬之寡聚物(5’-VCGCGTG-3’、20 mM)混 合之,於500mM卡可基酸緩衝液(50mM、pH7.0)中,使 用透照器以波長366 nm進行光照射。以90%以上之收率 成功完成募聚物之連結(第1圖;a),b))。 其次,對此溶液使用透照器以3 02 nm波長進行光照 丨— 餐 (請先閱讀背面之注意事項寫本頁) 裝 訂-------Γ
本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 6 311755 1239337
五、發明說明(7 ) 射時,成功地使大致定量的募聚物裂解(第工圖;b),c))。 然後利用ESI-TOFF測定5,-VCGCGTG-3,之分子量。 其結果如表2所示。 表2 £S 丨一TOFFmasscalcd. for CS0H75N23O35P5 (M — H), 1832.36: found· 1832.34 [產業上利用性之可行性] 如以上所詳述,依照本發明可選擇性地 獲得高連結收率,亦可將連結部分施以特異之光裂 解’而提供一種可自由控制可逆的光連結與光裂解的新技 術。 -------------裝---------訂· (請先閱讀背面之注意事項再填寫本頁}
經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 7 311755
Claims (1)
1239337 附 經濟部中央標準局員Η福利委員會印製
Ψ •气 笫89117263號專利申請宰 申請專利範圍修正本 ^ , 一 (92 年 8 月 28 曰) 牙由下式(1 )表示之可逆之光連結性核酸: NM.
m 等 % 本 案 i# 正 後 是 否 變 更 鳜 實 賀 内 t 4, H0·^ 〇 〇J-〇N OH X〇NA 種由下式(2)表示之磷醯胺酯: 0
(1) 一種光連結方法,其特徵為利用較33〇nm為長之波 之光照射如申請專利範圍第丨項之可逆之光連結性才 酸與屬於生體關連高分子之DNa、RNA、PNA或蛋 負之反應系,使形成兩者之連結構造者。 一種光解裂方法,其特徵為利用較32〇nrn為短之短〜 長之光照射如申請專利範圍第1項之可逆之光連結七 核酸與屬於生體關連高分子之DNA、RNA、PNA或 白質之連結構造而使之裂解者。 尽紙張尺度適用中國國家標進( - ¾ 公 / MS N 311755
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24068599 | 1999-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI239337B true TWI239337B (en) | 2005-09-11 |
Family
ID=17063194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW089117263A TWI239337B (en) | 1999-08-27 | 2000-08-25 | Reversible photocoupling nucleic acid and phosphoroamidite |
Country Status (5)
Country | Link |
---|---|
US (1) | US6593088B1 (zh) |
EP (1) | EP1125945B1 (zh) |
DE (1) | DE60002821T2 (zh) |
TW (1) | TWI239337B (zh) |
WO (1) | WO2001016151A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102820A1 (en) | 2001-06-20 | 2002-12-27 | Nuevolution A/S | Nucleoside derivatives for library preparation |
DE10147074A1 (de) * | 2001-09-25 | 2003-05-08 | Beru Ag | Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung |
DE20200926U1 (de) * | 2002-01-23 | 2002-04-18 | Hegenscheidt Mfd Gmbh & Co Kg | Festwalzgerät einer Festwalzmaschine für Kurbelwellen |
AU2003218630A1 (en) * | 2002-03-15 | 2003-09-29 | Nuevolution A/S | A building block capable of functional entity transfer to nucleophil |
WO2003078050A2 (en) * | 2002-03-15 | 2003-09-25 | Nuevolution A/S | A building block forming a c-c bond upon reaction |
AU2003218629A1 (en) * | 2002-03-15 | 2003-09-29 | Nuevolution A/S | A building block forming a c-c or a c-hetero atom bond uponreaction |
IL163822A0 (en) * | 2002-03-15 | 2005-12-18 | Nuevolution As | An improved method for synthesising templated molecules |
WO2004013070A2 (en) * | 2002-08-01 | 2004-02-12 | Nuevolution A/S | Multi-step synthesis of templated molecules |
PT1558744E (pt) * | 2002-10-30 | 2011-09-22 | Nuevolution As | Codificação enzimática |
ATE450609T1 (de) * | 2002-12-19 | 2009-12-15 | Nuevolution As | Durch quasizufallsstrukturen und funktionen geführte synthesemethode |
EP1597395A2 (en) * | 2003-02-21 | 2005-11-23 | Nuevolution A/S | Method for producing second-generation library |
WO2004074501A2 (en) * | 2003-02-21 | 2004-09-02 | Nuevolution A/S | A method for obtaining structural information about an encoded molecule |
ATE424455T1 (de) * | 2003-03-20 | 2009-03-15 | Nuevolution As | Ligationsvermittelnde codierung von kleinen molekülen |
EP1670939B1 (en) | 2003-09-18 | 2009-11-04 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
WO2005078122A2 (en) * | 2004-02-17 | 2005-08-25 | Nuevolution A/S | Method for enrichment involving elimination by mismatch hybridisation |
ATE447020T1 (de) * | 2004-03-22 | 2009-11-15 | Nuevolution As | Ligationscodierung unter verwendung von oligonukleotidbausteinen |
EP1956089B1 (en) * | 2005-11-17 | 2012-02-08 | Japan Science and Technology Agency | Method for detecting target nucleic acid with specific base sequence and set of nucleic acids for detection |
DE602006018648D1 (de) | 2005-12-01 | 2011-01-13 | Nuevolution As | Enzymvermittelnde kodierungsmethoden für eine effiziente synthese von grossen bibliotheken |
JP4814904B2 (ja) * | 2008-04-16 | 2011-11-16 | 国立大学法人北陸先端科学技術大学院大学 | 核酸類の配列選択的な精製方法 |
ES2713873T3 (es) | 2010-04-16 | 2019-05-24 | Nuevolution As | Complejos bifuncionales y métodos para hacer y utilizar tales complejos |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4849513A (en) * | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
US5449602A (en) | 1988-01-13 | 1995-09-12 | Amoco Corporation | Template-directed photoligation |
US5767264A (en) * | 1993-01-22 | 1998-06-16 | Mta Zozponti Kemiai Kutato Intezet | Oligodeoxynucleotides containing 5-alkyl, 5-(1-alkenyl)- and 5-(1-alkynl) pyrimidines |
HU212717B (en) * | 1993-01-22 | 1997-02-28 | Mta Koezponti Kemiai Kutato In | Oligonucleotides containing 5-alkyl-, 5-(1-alkenyl)- or 5-(1-alkynyl)-pyrimidine bases, pharmaceutical compositions containing them and process for their preparation |
JPH1129591A (ja) * | 1997-07-08 | 1999-02-02 | Kansai Shin Gijutsu Kenkyusho:Kk | 人工ヌクレアーゼ機能を有するオリゴデオキシリボヌクレオチド、ならびに、その製造用の中間体、その製造方法および使用方法 |
-
2000
- 2000-08-24 DE DE60002821T patent/DE60002821T2/de not_active Expired - Fee Related
- 2000-08-24 EP EP00954997A patent/EP1125945B1/en not_active Expired - Lifetime
- 2000-08-24 WO PCT/JP2000/005715 patent/WO2001016151A1/ja active IP Right Grant
- 2000-08-24 US US09/830,401 patent/US6593088B1/en not_active Expired - Lifetime
- 2000-08-25 TW TW089117263A patent/TWI239337B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60002821T2 (de) | 2004-05-06 |
EP1125945B1 (en) | 2003-05-21 |
US6593088B1 (en) | 2003-07-15 |
DE60002821D1 (en) | 2003-06-26 |
WO2001016151A1 (fr) | 2001-03-08 |
EP1125945A1 (en) | 2001-08-22 |
EP1125945A4 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI239337B (en) | Reversible photocoupling nucleic acid and phosphoroamidite | |
Zein et al. | Calicheamicin γ1I and DNA: molecular recognition process responsible for site-specificity | |
Weisbrod et al. | Novel strategies for the site-specific covalent labelling of nucleic acids | |
CA2452474C (en) | Nucleotide compositions comprising photocleavable markers and methods of preparation thereof | |
US7459443B2 (en) | Synthesis of biologically active compounds in cells | |
Greenberg et al. | DNA damage induced via 5, 6-dihydrothymid-5-yl in single-stranded oligonucleotides | |
AU676704B2 (en) | Sequence-specific binding polymers for duplex nucleic acids | |
Zatsepin et al. | Use of carbonyl group addition− elimination reactions for synthesis of nucleic acid conjugates | |
US20030092046A1 (en) | Guanidinium functionalized oligomers and methods | |
JPH07505903A (ja) | オリゴヌクレオチド合成に有用な保護基 | |
AU2002354577A1 (en) | Nucleotide compositions comprising photocleavable markers and methods of preparation thereof | |
EP0215942A4 (en) | REAGENT AND METHOD FOR THE ANALYSIS OF POLYNUCLEOTIDES. | |
JPH07502749A (ja) | Rnaを調節するための組成物と方法 | |
KR20220163359A (ko) | 신규 mRNA 5'-말단 캡 유사체, 이를 혼입한 RNA 분자, 이의 용도 및 RNA 분자 또는 펩티드의 합성 방법 | |
WO2008141799A1 (en) | Oligophosphoramidates | |
JPWO2007058326A1 (ja) | 特定の塩基配列の標的核酸類を検出する方法、及び検出のための核酸類セット | |
Warminski et al. | Synthesis of RNA 5′-Azides from 2′-O-Pivaloyloxymethyl-Protected RNAs and Their Reactivity in Azide–Alkyne Cycloaddition Reactions | |
WO1992000989A1 (en) | Non-isotopic nucleic acid labelling method | |
JP2015006150A (ja) | 鎖交換された二重鎖オリゴヌクレオチドの製造方法 | |
Wiessler et al. | Extension of the PNA world by functionalized PNA monomers eligible candidates for inverse Diels Alder Click Chemistry | |
Fujimoto et al. | Sequence dependent photoreduction of 5-bromouracil-contaning oligonucleotides via electron transfer | |
Rydzik et al. | Access to 1′-Amino Carbocyclic Phosphoramidite to Enable Postsynthetic Functionalization of Oligonucleotides | |
Ovadia et al. | Contribution to PNA–RNA Chimera Synthesis: One‐Pot Microwave‐Assisted Ugi Reaction to Obtain Dimeric Building Blocks | |
Allart et al. | 1, 5-Anhydro-2-deoxy-D-altritol oligonucleotides as conformationally restricted analogues of RNA | |
JP2001139594A (ja) | 可逆的光連結性核酸とフォスフォロアミダイト |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |